» Articles » PMID: 34166383

Vancomycin Resistant Enterococci and Its Associated Factors Among HIV Infected Patients on Anti-retroviral Therapy in Ethiopia

Overview
Journal PLoS One
Date 2021 Jun 24
PMID 34166383
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The emergence of vancomycin resistant Enterococci (VRE) has alarmed the global community due to its tendency for colonization of the gastrointestinal tract. Human Immunodeficiency Virus (HIV) patients are colonized by vancomycin resistant Enterococci than other groups. The aim of this study was to determine the incidence of vancomycin resistant Enterococci and its associated factors among HIV infected patients on Anti-Retroviral Therapy (ART).

Methods: Institution based cross sectional study was conducted among HIV infected patients on ART at from June 1 to August 30, 2020. Socio-demographic and clinical data were collected by pre-tested structured questionnaire. Stool sample was collected and processed by standard microbiological techniques. Kirby Bauer Disc diffusion method was used to perform antimicrobial susceptibility testing. Data were entered by Epi data version 4.6.0.2 and analyzed by SPSS version 25. Bivariable and multivariable logistic regression model was used to analyze the association between dependent and independent variables. P-values in the multivariable analysis, adjusted odds ratio (AOR) and 95% confidence interval (CI) were used to determine the strength of association. P-value ≤0.05 was considered as significant.

Results: Enterococci spp was isolated on 123/200 (61.50%) patients. Among these isolates, the incidence of vancomycin resistant Enterococci was 11.4% [95% CI: (6.0-17.0)]. Antimicrobial susceptibility patterns against Enterococci showed highest rate of resistance to ampicillin (69.9%). Multidrug resistances were observed in 49.59% of Enterococci isolates. Study participants who had prior antibioticexposurer more than two weeks [AOR = 7.35; 95% CI: (1.2144.64)] and hospitalization for the last six months [AOR = 5.68; 95% CI: (1.09 29.74)] were significantly associated with vancomycin resistant Enterococci.

Conclusions: In our study high incidence of vancomycin resistant Enterococci was found. Previous exposure to antibiotics for more than two weeks and hospitalization for more than six months were significantly associated with vancomycin resistant Enterococci. The isolated Enterococci had variable degrees of resistance to commonly prescribed antibiotics. Therefore, periodic surveillance on antimicrobial resistance pattern, adhering to rational use of antibiotics and implementing infection prevention protocols may reduce colonization by VRE.

Citing Articles

Multidrug-Resistant Bacteria in Immunocompromised Patients.

Duhaniuc A, Paduraru D, Nastase E, Trofin F, Iancu L, Sima C Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338313 PMC: 11434862. DOI: 10.3390/ph17091151.


Burden of multidrug-resistant bacteria among HIV-positive individuals in Ethiopia: A systematic review and meta-analysis.

Assefa M, Amare A, Tigabie M, Girmay G, Setegn A, Wondmagegn Y PLoS One. 2024; 19(8):e0309418.

PMID: 39186717 PMC: 11346931. DOI: 10.1371/journal.pone.0309418.


High Gastrointestinal Colonization Rate of Vancomycin-Resistant among Hospitalized Patients: Potential Source for Resistant Gene.

Mengesha T, Ali M, Mengistu M, Fenta D Int J Microbiol. 2024; 2024:6430026.

PMID: 38226181 PMC: 10789508. DOI: 10.1155/2024/6430026.


Vancomycin Resistant Enterococci Prevalence, Antibiotic Susceptibility Patterns and Colonization Risk Factors Among HIV-Positive Patients in Health-Care Facilities in Debre Berhan Town, Ethiopia.

Zike M, Ahmed A, Hailu A, Hussien B Infect Drug Resist. 2024; 17:17-29.

PMID: 38192330 PMC: 10771780. DOI: 10.2147/IDR.S440479.


Antibiotic Susceptibility Patterns and Virulence-Associated Factors of Vancomycin-Resistant Enterococcal Isolates from Tertiary Care Hospitals.

Backiam A, Duraisamy S, Karuppaiya P, Balakrishnan S, Chandrasekaran B, Kumarasamy A Antibiotics (Basel). 2023; 12(6).

PMID: 37370300 PMC: 10295198. DOI: 10.3390/antibiotics12060981.


References
1.
Toru M, Beyene G, Kassa T, Gizachew Z, Howe R, Yeshitela B . Prevalence and phenotypic characterization of Enterococcus species isolated from clinical samples of pediatric patients in Jimma University Specialized Hospital, south west Ethiopia. BMC Res Notes. 2018; 11(1):281. PMC: 5941600. DOI: 10.1186/s13104-018-3382-x. View

2.
Nilsson O . Vancomycin resistant enterococci in farm animals - occurrence and importance. Infect Ecol Epidemiol. 2012; 2. PMC: 3426332. DOI: 10.3402/iee.v2i0.16959. View

3.
Amberpet R, Sistla S, Parija S, Rameshkumar R . Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit. J Lab Physicians. 2018; 10(1):89-94. PMC: 5784302. DOI: 10.4103/JLP.JLP_32_17. View

4.
Achenbach C, Flores E, Ferrell P, Pitrak D, Weber S . Prevalence of and risk factors for colonization with vancomycin-resistant enterococcus among human immunodeficiency virus-positive outpatients. Infect Control Hosp Epidemiol. 2006; 27(1):102-4. DOI: 10.1086/499391. View

5.
Alotaibi F, Bukhari E . Emergence of Vancomycin-resistant at a Teaching Hospital, Saudi Arabia. Chin Med J (Engl). 2017; 130(3):340-346. PMC: 5308018. DOI: 10.4103/0366-6999.198923. View